SheelaTejwaniMD

PubMed

• A Case of Immune-Mediated Pneumonitis Associated With Dual Nivolumab and Ipilimumab Immunotherapy Treatment.
  Tala Al-Saghir, Noor Suleiman, Benjamin D Goodman, Michael W Ferguson, Sheela Tejwani> ;Cureus. 2023 Jun 1
• 3 citations
  Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study.
  Wagner, M., Hennessy, C., Beeghly, A., French, B., Shah, D., Croessmann, S., Vilar-Compte, D., Ruiz-Garcia, E., Ingham, M., Schwartz, G., Painter, C., Chugh, R., Feche...> ;Cancers. 2022 Sep 5
• 27 citations
  Clinical Efficacy of Enzalutamide vs Bicalutamide Combined With Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer: A Randomized Cli...
  Ulka N. Vaishampayan, Lance K. Heilbrun, Paul Monk, Sheela Tejwani, Guru Sonpavde, Clara Hwang, Daryn Smith, Pallavi Jasti, Kimberlee Dobson, Brenda Dickow, Elisabeth ...> ;JAMA Network Open. 2021 Jan 4
• SAPHO Syndrome Masquerading as Metastatic Breast Cancer.
  Devin Malik, Richa Handa, Andrew Petraszko, Sheela Tejwani> ;Case Reports in Rheumatology. 2018 Mar 20
• 437 citations
  Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500
  Jeffrey B. Smerage, William E. Barlow, Gabriel N. Hortobagyi, Eric P. Winer, Brian Leyland-Jones, Gordan Srkalovic, Sheela Tejwani, Anne F. Schott, Mark Allen O'Rourke...> ;Journal of Clinical Oncology. 2014 Nov 1
• 414 citations
  Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study
  Susan F. Slovin, Celestia S. Higano, Omid Hamid, Sheela Tejwani, Andrea L. Harzstark, Joshi J. Alumkal, Howard I. Scher, Kevin M. Chin, Paul Gagnier, M.B. McHenry, Tom...> ;Annals of Oncology. 2013 Jul 1
• 15 citations
  Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate Cancer.
  Shin Ogita, Sheela Tejwani, Lance K. Heilbrun, Joseph A. Fontana, Elisabeth I. Heath, Stacy Freeman, Daryn Smith, Karen Baranowski, Ulka N. Vaishampayan> ;ISRN Oncology. 2012 Jun 13
• Ipilimumab (IPI) in metastatic castrate-resistant prostate cancer (mCRPC): Results from an open-label, multicenter phase I/II study.
  Slovin SF, Hamid O, Tejwani S, Higano CS, Harzstark A, Alumkal JJ, Scher HI, Chin KM, Gagnier P, McHenry MB, Beer TM> ;J. Clin. Oncol.. 2012-02-10
• Phase II trial of bevacizumab monotherapy in nonmetastatic castrate-resistant prostate cancer (CRPC).
  Ogita S, Tejwani S, Heilbrun LK, Fontana JA, Heath EI, Freeman S, Smith DW, Baranowski K, Vaishampayan UN> ;J. Clin. Oncol.. 2011-03-01
• 37 citations
  Androgen regulated TRPM8 expression: A potential mRNA marker for metastatic prostate cancer detection in body fluids
  V. Uma Bai, Shalini Murthy, Kannagi Chinnakannu, Fred Muhletaler, Sheela Tejwani, Evelyn R. Barrack, Sahn-Ho Kim, Mani Menon, G. Prem Veer Reddy> ;International Journal of Oncology. 2009 Dec 27
• Initial phase II experience of ipilimumab (IPI) alone and in combination with radiotherapy (XRT) in patients with metastatic castration-resistant prostate cancer (mCRPC).
  Slovin SF, Beer TM, Higano CS, Tejwani S, Hamid O, Picus J, Harzstark A, Scher HI, Lan Z, Lowy I> ;J. Clin. Oncol.. 2009-05-20
• Phase I trial of ipilimumab (IPI) alone and in combination with radiotherapy (XRT) in patients with metastatic castration resistant prostate cancer (mCRPC).
  Beer TM, Slovin SF, Higano CS, Tejwani S, Dorff TB, Stankevich E, Lowy I> ;J. Clin. Oncol.. 2008-05-20
• 136 citations
  Androgen Receptor– and E2F-1–Targeted Thymoquinone Therapy for Hormone-Refractory Prostate Cancer
  Ahmed Kaseb, Kannagi Chinnakannu, Di Chen, Arun Sivanandam, Sheela Tejwani, Mani Menon, Q. Ping Dou, G. Prem Veer Reddy> ;Cancer Research. 2007 Aug 15
• 24 citations
  Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine
  V. Uma Bai, Ahmed Kaseb, Sheela Tejwani, George Divine, Evelyn R. Barrack, Mani Menon, Arthur B. Pardee, G. Prem Veer Reddy> ;Proceedings of the National Academy of Sciences of the United States of America. 2007 Feb 13
• Thymoquinone, a component of the herb Nigella sativa, suppresses proliferation and viability of prostate cancer cells by down-regulating androgen receptor and E2F-1.
  Kaseb AO, Tejwani S, Chinnakannu K, Barrack E, Reddy P> ;J. Clin. Oncol.. 2006-06-20
• Stress management in breast cancer patients by healing breath program.
  Kamboj G, Tejwani SS, Nangia-Makker P, Oja-Tebbe N> ;J. Clin. Oncol.. 2004-07-15
• 51 citations
  Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy
  Lisa Rogers, Sandra E. Remer, Sheela Tejwani> ;Neuro-Oncology. 2004 Jan 1
• Join now to see all